As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is important for policymakers to understand the distinct differences between broad categories of therapies as they examine potential solutions.

This paper seeks to explain differences between the basic types of drugs. While there is significant variation within each of the broad categories, knowing the differences between the basic types of drugs can shed light on market dynamics, the competitive environment, and other factors that contribute to manufacturers’ drug pricing decisions.

Full paper: Drug policy 101: Breaking down different types of drug therapies

Other papers in this series: